NeuroSENSE Monitoring System, Model NS-901— 510(k) K202621

Substantially Equivalent

Neurowave Systems, Inc.

FDA 510(k) clearance K202621 for NeuroSENSE Monitoring System, Model NS-901, Substantially Equivalent on 2021-08-05. Applicant: Neurowave Systems, Inc..

Clearance details

Applicant: Neurowave Systems, Inc.
Product code: Code OLW
Advisory panel: Neurology
Date received: 2020-09-10
Decision date: 2021-08-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cleveland Heights, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.